MALPEZZI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.179
NA - Nord America 2.145
EU - Europa 1.564
SA - Sud America 252
AF - Africa 61
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 8
Totale 6.250
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.034
CN - Cina 751
IT - Italia 628
SG - Singapore 600
BR - Brasile 194
VN - Vietnam 193
HK - Hong Kong 188
DE - Germania 179
GB - Regno Unito 133
KR - Corea 132
SE - Svezia 120
FR - Francia 85
RU - Federazione Russa 85
FI - Finlandia 58
CA - Canada 55
ID - Indonesia 50
ES - Italia 48
IN - India 46
NL - Olanda 43
BD - Bangladesh 40
JP - Giappone 35
LT - Lituania 28
BE - Belgio 27
IQ - Iraq 25
CH - Svizzera 22
PL - Polonia 18
AR - Argentina 15
MX - Messico 15
ZA - Sudafrica 15
IR - Iran 14
AT - Austria 13
CL - Cile 13
IE - Irlanda 13
TR - Turchia 13
CZ - Repubblica Ceca 10
EC - Ecuador 10
MY - Malesia 10
PH - Filippine 10
SA - Arabia Saudita 10
TW - Taiwan 10
UZ - Uzbekistan 10
MA - Marocco 9
UA - Ucraina 9
IL - Israele 8
PK - Pakistan 8
GR - Grecia 7
PY - Paraguay 7
TN - Tunisia 7
AU - Australia 6
DZ - Algeria 6
HN - Honduras 6
TT - Trinidad e Tobago 6
VE - Venezuela 6
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
GT - Guatemala 5
JM - Giamaica 5
KE - Kenya 5
NI - Nicaragua 5
BY - Bielorussia 4
CR - Costa Rica 4
EG - Egitto 4
HU - Ungheria 4
KZ - Kazakistan 4
LI - Liechtenstein 4
NO - Norvegia 4
PR - Porto Rico 4
PT - Portogallo 4
RO - Romania 4
RS - Serbia 4
SC - Seychelles 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JO - Giordania 3
MO - Macao, regione amministrativa speciale della Cina 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BH - Bahrain 2
CO - Colombia 2
GH - Ghana 2
LB - Libano 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AD - Andorra 1
BO - Bolivia 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
Totale 6.213
Salva come PNG Salva come JPEG
Città #
Hefei 379
Singapore 376
Santa Clara 344
San Jose 270
Ashburn 252
Hong Kong 179
Council Bluffs 172
Seoul 119
Modena 86
Ho Chi Minh City 71
Frankfurt am Main 67
Beijing 66
London 66
Los Angeles 55
New York 54
Bologna 48
Milan 43
The Dalles 39
Jakarta 38
Munich 38
Hanoi 37
Helsinki 37
Nyköping 33
Boardman 30
Chandler 26
Lauterbourg 26
Reggio Emilia 26
Dallas 24
Parma 23
Buffalo 22
Kent 21
Orem 21
Shanghai 21
Chicago 20
Moscow 20
Amsterdam 18
Padova 17
Rome 17
Warsaw 16
Atlanta 15
Barcelona 15
Denver 15
Leuven 15
Padua 15
Phoenix 15
São Paulo 15
Washington 15
Hangzhou 14
Decatur 13
Lappeenranta 13
Madrid 13
Chennai 12
Tokyo 12
Toronto 12
Zurich 11
Boston 10
Da Nang 10
Manchester 10
Santiago 10
Tehran 10
Brooklyn 9
Brussels 9
Dublin 9
Montreal 9
Tashkent 9
Turin 9
Charlotte 8
Formigine 8
Nuremberg 8
Princeton 8
Stockholm 8
Vienna 8
Argenta 7
Athens 7
Biên Hòa 7
Ferrara 7
Kuala Lumpur 7
Mexico City 7
Ottawa 7
Paris 7
Poplar 7
Vilnius 7
Belo Horizonte 6
Brno 6
East Wenatchee 6
Guangzhou 6
Johannesburg 6
Lansdowne 6
Leipzig 6
Osnabrück 6
Rossdorf 6
San Diego 6
Seattle 6
Turku 6
Addis Ababa 5
Ankara 5
Calgary 5
Cebu City 5
Florence 5
Hillsboro 5
Totale 3.761
Salva come PNG Salva come JPEG
Nome #
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 328
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 293
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 262
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 257
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 257
Applying optical tweezers technology to reveal Thymidylate Synthase interactions with its consensus mRNA 246
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 240
Current Treatments to Control African Trypanosomiasis and One Health Perspective 230
Exploring thymidylate synthase mRNA binding site 1 and human TS protein interaction with optical tweezers and bicistronic expression assay 225
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 208
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 208
Exploiting the Optical Tweezer technology to reveal thymidylate synthase interactions with its consensus mRNA 204
EXPLOITING THE OPTICAL TWEEZER, A SINGLE MOLECULE TECHNOLOGY, TO REVEAL THYMIDYLATE SYNTHASE INTERACTIONS WITH ITS CONSENSUS mRNA 203
Drug discovery of pyrazolo-piperidinone inhibitors targeting YAP:TEAD interaction and development of a fluorescence anisotropy assay for high-throughput screening 201
Advancing sustainable drug development: comparative preclinical study of H80 and Miltefosine using imaging and proteomics 195
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 194
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 191
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 186
Optical tweezers to investigate at the single-molecule level the interaction of thymidylate synthase with its consensus mRNA 185
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 185
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 178
Leveraging proteomic, bioinformatic and ecotoxicology models to select new targets overcoming L. Infantum drug resistent 178
One Health Approach in Drug Discovery for Leishmaniasis by Targeting Calpain cys-protease. 176
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 174
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 166
Promoting A Sustainable Medicinal Chemistry Approach With The Cost Action CA21111 - One Health Drugs Against Parasitic Vector Borne Diseases In Europe And Beyond 146
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 142
Leveraging proteomics, bioinformatics, and ecotoxicology models to select new targets overcoming L infantum drug resistance. 139
Preclinical investigation of H80 compared to miltefosine: imaging and proteomics for sustainable drug development 118
Development of a fluorescent anisotropy displacement assay for the optimization of YAP:TEAD molecular disrupters with anticancer activity 116
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS 115
Meccanismi on-target di farmaci innovativi antitumorali e anti-infettivi studiati mediante approcci biochimici e biofisici 94
Targeting the YAP:TEAD domain through fluorescence-anisotropy displacement assay 10
Totale 6.250
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 0 0 17 9 6 12 4 22 13
2022/2023272 35 23 14 18 13 20 18 35 50 1 31 14
2023/2024651 38 43 47 28 146 38 65 54 16 9 98 69
2024/20251.723 55 33 64 101 290 252 135 89 169 70 249 216
2025/20262.777 252 209 284 353 322 143 354 131 247 261 138 83
2026/2027744 80 99 191 296 78 0 0 0 0 0 0 0
Totale 6.250